Pages that link to "Q33933021"
Jump to navigation
Jump to search
The following pages link to Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene (Q33933021):
Displaying 11 items.
- Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer (Q37389608) (← links)
- Clinical significance of post-progression survival in lung cancer (Q38669447) (← links)
- Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide (Q39572955) (← links)
- Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations (Q41728235) (← links)
- The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer. (Q52672760) (← links)
- Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data (Q58769992) (← links)
- CHALLENGES AND METHODOLOGIES IN USING PROGRESSION FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN ONCOLOGY (Q89485600) (← links)
- Post-progression survival is highly linked to overall survival in patients with non-small-cell lung cancer harboring sensitive EGFR mutations treated with first-line epidermal growth factor receptor-tyrosine kinase inhibitors (Q90603043) (← links)
- Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer (Q92364788) (← links)
- Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer (Q92413747) (← links)
- Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set (Q92562602) (← links)